# PIII (P3 Health Partners Inc.) - SEC EDGAR Financial Statements

> P3 Health Partners Inc. reported $1.55B in revenue and a net loss of $51.23M for the trailing twelve months ended September 30, 2026 (up 14.8% year over year), with a -5.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/PIII
- Markdown: https://convexityos.com/fundamentals/PIII.md
- SEC CIK: 0001832511
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001832511&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.55B | +14.8% YoY |
| Operating Income | TTM | -$81.42M | -5.2% margin |
| Net Income | TTM | -$51.23M | -3.3% net margin |
| Diluted EPS | TTM | -$7.73 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $43.90M | Total debt: $131.9M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.46B | $1.50B | $1.27B | $1.05B | $578.6M | $491.1M | $145.5M |
| Selling, General & Admin | $107.2M | $113.9M | $125.6M | $162.4M | $102.1M | $54.89M | $37.23M |
| Total Operating Expenses | $1.73B | $1.82B | $1.43B | $2.61B | $707.7M | $519.7M | $185.0M |
| **Operating Income** | -$270.3M | -$320.7M | -$167.9M | -$1.56B | -$129.1M | -$28.59M | -$39.54M |
| **EBITDA** | -$186.1M | -$234.6M | -$81.25M | -$1.47B | -$127.5M | -$27.79M | -$39.14M |
| Income Before Tax | -$321.1M | -$306.0M | -$183.7M | -$1.56B | -$146.4M | -$31.41M | -$41.97M |
| Income Tax Expense | $2.02M | $4.39M | $2.69M | $1.86M | $0 | $0 | $0 |
| **Net Income** | -$147.9M | -$135.8M | -$57.77M | -$270.1M | -$146.4M | -$31.41M | -$41.97M |
| Basic EPS | -$45.26 | -$46.78 | -$30.50 | -$325.00 | -- | -- | -- |
| **Diluted EPS** | -$45.26 | -$54.06 | -$31.50 | -$325.00 | -- | -- | -- |
| Basic Shares Outstanding | 3.3M | 2.9M | 1.9M | 831.6K | -- | -- | -- |
| Diluted Shares Outstanding | 3.3M | 2.9M | 5.9M | 831.6K | -- | -- | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $396.3M | $386.4M | $386.4M | $384.8M | $345.3M | $355.8M | $373.2M | $370.7M |
| Selling, General & Admin | -- | -- | $25.77M | $35.63M | $22.64M | $23.60M | $25.18M | $31.83M |
| Total Operating Expenses | $373.4M | $345.2M | $378.2M | $538.7M | $389.5M | $389.9M | $411.3M | $509.2M |
| **Operating Income** | $22.98M | $41.23M | $8.24M | -$153.9M | -$44.22M | -$34.12M | -$38.09M | -$138.5M |
| **EBITDA** | $44.02M | $62.27M | $29.31M | -$132.9M | -$23.19M | -$13.04M | -$17.04M | -$117.3M |
| Income Before Tax | $30.80M | $16.92M | -$7.96M | -$166.8M | -$69.45M | -$41.68M | -$43.17M | -$124.2M |
| Income Tax Expense | $23K | $1.26M | -$11.00M | -$1.04M | $11K | $1.98M | $1.07M | $4.95M |
| **Net Income** | $15.62M | $7.44M | $1.22M | -$75.52M | -$31.59M | -$20.36M | -$20.48M | -$58.62M |
| Basic EPS | $0.13 | -$0.63 | $0.37 | -- | -$9.67 | -$6.23 | -$6.28 | -- |
| **Diluted EPS** | $0.07 | -$0.63 | $0.32 | -- | -$9.67 | -$6.23 | -$6.28 | -- |
| Basic Shares Outstanding | 3.4M | 3.4M | 3.3M | -- | 3.3M | 3.3M | 3.3M | -- |
| Diluted Shares Outstanding | 6.6M | 3.4M | 8.4M | -- | 3.3M | 3.3M | 3.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $25.01M | $38.82M | $36.32M | $17.54M | $140.5M | $36.26M |
| **Cash & Short-Term Investments** | $25.01M | $38.82M | $36.32M | $17.54M | $140.5M | $36.26M |
| **Total Current Assets** | $133.1M | $184.1M | $166.0M | $100.7M | $199.9M | $90.88M |
| Property, Plant & Equipment, Net | $3.37M | $5.73M | $8.69M | $8.84M | $8.05M | $6.15M |
| Goodwill | -- | -- | -- | $0 | $1.31B | $871K |
| Intangible Assets | $492.4M | $574.4M | $666.7M | $751.0M | $835.8M | -- |
| Other Non-Current Assets | $27.76M | $19.20M | $19.53M | $15.99M | $10.61M | -- |
| **Total Non-Current Assets** | $523.6M | $599.3M | $695.0M | $775.9M | $2.16B | $15.55M |
| **Total Assets** | $656.6M | $783.4M | $861.0M | $876.6M | $2.36B | $106.4M |
| Accounts Payable | $11.71M | $8.44M | $8.66M | $11.54M | $5.47M | -- |
| Short-Term Debt | $45.04M | $75.16M | $0 | $0 | $3.62M | $90K |
| **Total Current Liabilities** | $545.3M | $496.4M | $299.4M | $241.7M | $198.8M | $90.62M |
| Long-Term Debt | $228.4M | $108.9M | $108.3M | $94.42M | $80.00M | $45.39M |
| Other Non-Current Liabilities | $9.31M | $6.92M | $0 | -- | -- | -- |
| **Total Non-Current Liabilities** | $251.6M | $137.5M | $127.9M | $112.2M | $101.2M | $55.34M |
| **Total Liabilities** | $796.9M | $633.9M | $427.3M | $353.9M | $299.9M | $146.0M |
| **Total Debt (incl. Leases)** | $287.3M | $197.9M | $124.7M | $107.2M | $92.01M | $51.29M |
| Retained Earnings | -$651.1M | -$503.2M | -$367.3M | -$309.5M | -$39.42M | -$130.5M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | $447K |
| **Total Stockholders' Equity** | -$155.2M | $75.94M | $142.1M | $5.85M | $273.6M | $23K |
| Total Equity | -$155.2M | $75.94M | $142.1M | $5.85M | $273.6M | $23K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $43.90M | $21.27M | $25.50M | $25.01M | $37.71M | $38.58M | $40.08M | $38.82M |
| **Cash & Short-Term Investments** | $43.90M | $21.27M | $25.50M | $25.01M | $37.71M | $38.58M | $40.08M | $38.82M |
| **Total Current Assets** | $216.0M | $179.3M | $172.2M | $133.1M | $135.6M | $156.5M | $191.4M | $184.1M |
| Property, Plant & Equipment, Net | $2.15M | $2.53M | $2.96M | $3.37M | $3.90M | $4.69M | $5.31M | $5.73M |
| Intangible Assets | $431.8M | $452.4M | $473.0M | $492.4M | $512.9M | $533.4M | $553.9M | $574.4M |
| Other Non-Current Assets | $19.73M | $20.12M | $25.99M | $27.76M | $31.12M | $36.97M | $33.24M | $19.20M |
| **Total Non-Current Assets** | $453.7M | $475.1M | $501.9M | $523.6M | $547.9M | $575.1M | $592.4M | $599.3M |
| **Total Assets** | $669.7M | $654.4M | $674.2M | $656.6M | $683.6M | $731.6M | $783.9M | $783.4M |
| Accounts Payable | $7.70M | $7.57M | $11.67M | $11.71M | $9.93M | $14.39M | $11.50M | $8.44M |
| Short-Term Debt | $84.53M | $22.22M | $52.27M | $45.04M | $38.73M | $80.45M | $65.80M | $75.16M |
| **Total Current Liabilities** | $406.6M | $388.6M | $525.5M | $545.3M | $424.0M | $505.0M | $507.0M | $496.4M |
| Long-Term Debt | $37.33M | $98.05M | $259.6M | $228.4M | $214.2M | $102.0M | $106.1M | $108.9M |
| Other Non-Current Liabilities | $9.31M | $9.31M | $9.31M | $9.31M | $6.92M | $22.16M | $31.66M | $6.92M |
| **Total Non-Current Liabilities** | $62.36M | $128.2M | $281.8M | $251.6M | $240.7M | $139.4M | $155.8M | $137.5M |
| **Total Liabilities** | $469.0M | $516.7M | $807.3M | $796.9M | $664.6M | $644.4M | $662.8M | $633.9M |
| **Total Debt (incl. Leases)** | $131.9M | $130.7M | $322.7M | $287.3M | $265.0M | $192.7M | $182.9M | $197.9M |
| Retained Earnings | -$626.9M | -$642.5M | -$649.9M | -$651.1M | -$575.6M | -$544.0M | -$523.7M | -$503.2M |
| **Total Stockholders' Equity** | -- | -- | -- | -$155.2M | -$18.69M | $44.46M | $63.25M | $75.94M |
| Total Equity | $110.5M | $73.19M | -$143.5M | -$155.2M | -$18.69M | $44.46M | $63.25M | $75.94M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$323.1M | -$310.4M | -$186.4M | -$1.56B | -$146.4M | -$31.41M | -$41.97M |
| Depreciation & Amortization | $84.16M | $86.06M | $86.67M | $87.29M | $1.57M | $795K | $399K |
| Stock-Based Compensation | $5.58M | $5.75M | $5.98M | $19.40M | $3.70M | $447K | $474K |
| Change in Receivables | -- | -- | -- | -- | -$1.48M | $139K | $424K |
| Change in Payables | -- | -- | -- | -- | $34.22M | $8.10M | $804K |
| **Operating Cash Flow** | -$91.24M | -$110.1M | -$76.03M | -$126.0M | -$51.13M | -$24.60M | -$28.29M |
| Capital Expenditure | -- | $0 | -$1.83M | -$2.23M | -$3.29M | -$2.93M | -$1.45M |
| **Free Cash Flow** | -- | -$110.1M | -$77.86M | -$128.3M | -$54.42M | -$27.52M | -$29.74M |
| **Investing Cash Flow** | $129K | $14.53M | -$1.83M | -$7.73M | -$8.21M | -$3.17M | -$3.86M |
| **Financing Cash Flow** | $72.81M | $98.77M | $100.3M | $11.38M | $24.79M | $34.76M | $63.62M |
| **Net Change in Cash** | -$18.30M | $3.17M | $22.48M | -$122.4M | -$34.55M | $7.00M | $31.48M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $30.78M | $15.65M | $3.04M | -$165.7M | -$69.46M | -$43.66M | -$44.25M | -$129.1M |
| Depreciation & Amortization | $21.04M | $21.04M | $21.07M | $21.00M | $21.03M | $21.08M | $21.05M | $21.15M |
| Stock-Based Compensation | -$421K | $866K | $1.05M | $1.10M | $1.21M | $1.46M | $1.81M | $721K |
| **Operating Cash Flow** | -$685K | -$61.91M | -$27.47M | -$25.73M | -$15.41M | -$16.63M | -$33.47M | -$57.24M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$57.24M |
| **Investing Cash Flow** | $0 | -$208K | -$43K | $198K | -$119K | $50K | $0 | -$475K |
| **Financing Cash Flow** | $24.29M | $58.21M | $27.80M | $12.87M | $14.67M | $14.62M | $30.66M | $33.72M |
| **Net Change in Cash** | $23.61M | -$3.91M | $295K | -$12.65M | -$865K | -$1.97M | -$2.81M | -$24.00M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -18.5% | -21.4% | -13.3% | -148.7% | -22.3% | -5.8% | -27.2% |
| **Net Profit Margin** | -10.1% | -9.1% | -4.6% | -25.7% | -25.3% | -6.4% | -28.8% |
| Return on Equity (ROE) | -- | -178.9% | -40.6% | -4614.4% | -53.5% | -138291.5% | -- |
| Return on Assets (ROA) | -22.5% | -17.3% | -6.7% | -30.8% | -6.2% | -29.5% | -- |
| Current Ratio | 0.24x | 0.37x | 0.55x | 0.42x | 1.01x | 1.00x | -- |
| Quick Ratio | 0.05x | 0.08x | 0.12x | 0.07x | 0.71x | 0.40x | -- |
| Debt to Equity | -- | 2.61x | 0.88x | 18.31x | 0.34x | 2257.92x | -- |
| **Revenue Growth (YoY)** | -2.8% | +18.5% | +20.7% | +81.4% | +17.8% | +237.5% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -5.2% | -9.9% | -15.2% | -18.5% | -17.6% | -21.7% | -21.2% | -21.4% |
| **Net Profit Margin** | -3.3% | -6.6% | -8.6% | -10.1% | -9.1% | -10.0% | -9.3% | -9.1% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -328.3% | -217.6% | -178.9% |
| Return on Assets (ROA) | -7.6% | -15.0% | -18.7% | -22.5% | -19.2% | -20.0% | -17.6% | -17.3% |
| Current Ratio | 0.53x | 0.46x | 0.33x | 0.24x | 0.32x | 0.31x | 0.38x | 0.37x |
| Quick Ratio | 0.11x | 0.05x | 0.05x | 0.05x | 0.09x | 0.08x | 0.08x | 0.08x |
| Debt to Equity | -- | -- | -- | -- | -- | 4.33x | 2.89x | 2.61x |
| **Revenue Growth (YoY)** | +14.8% | +8.6% | +3.5% | +3.8% | -4.7% | -6.2% | -3.9% | +6.9% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
